Tan IIA has been shown to increase CXCL12 expression at the site of injury as well as CXCR4 on transplanted MSCs, leading to enhanced MSC migration to the injured area, which may prove effective in the treatment of ischemic heart disease (Tong et al., 2011). The gene discussed is CXCL12; the disease is coronary artery disorder.